Two EpCAM-positive cell lines, MCF-7 (a breast cancer cell line) and the CHO–EpCAM cell line used for antibody selections, were used as targets and both Jurkat cells and CD3+ T cells derived from human peripheral blood mononuclear cells (PBMCs) were used as effector cells. Here, EPCAM is linked to breast carcinoma.